The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.

Por de Verneuil, H, Metzger, D
Publicado em 1990

Community-level HIV intervention work for women means restructuring society and culture.

Por Gollub, E L, Metzger, D
Publicado em 1999

Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.

Por Berry, M, Metzger, D, Chambon, P
Publicado em 1990

Drug abuse treatment as AIDS prevention.

Por Metzger, D S, Navaline, H, Woody, G E
Publicado em 1998

Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase.

Por Metzger, D, Clifford, J, Chiba, H, Chambon, P
Publicado em 1995

A chimeric Cre recombinase inducible by synthetic,but not by natural ligands of the glucocorticoid receptor.

Por Brocard, J, Feil, R, Chambon, P, Metzger, D
Publicado em 1998

Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells.

Por Chiba, H, Clifford, J, Metzger, D, Chambon, P
Publicado em 1997

Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region.

Por Ali, S, Metzger, D, Bornert, J M, Chambon, P
Publicado em 1993

Mammalian TAF(II)30 is required for cell cycle progression and specific cellular differentiation programmes.

Por Metzger, D, Scheer, E, Soldatov, A, Tora, L
Publicado em 1999

SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells.

Por Sumi-Ichinose, C, Ichinose, H, Metzger, D, Chambon, P
Publicado em 1997

ANCA in diseases other than systemic vasculitis.

Por Peter, H H, Metzger, D, Rump, A, Röther, E
Publicado em 1993

RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids.

Por Clifford, J, Chiba, H, Sobieszczuk, D, Metzger, D, Chambon, P
Publicado em 1996

Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast.

Por Metzger, D, Losson, R, Bornert, J M, Lemoine, Y, Chambon, P
Publicado em 1992

Positive selection of major histocompatibility complex-restricted suppressor T cells bearing the predominant idiotype in the immune response to lysozyme.

Por Araneo, B A, Yowell, R L, Metzger, D W, Sercarz, E E
Publicado em 1981

The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties.

Por Tora, L, Mullick, A, Metzger, D, Ponglikitmongkol, M, Park, I, Chambon, P
Publicado em 1989

HIV vaccine trials: will intravenous drug users enroll?

Por Meyers, K, Metzger, D S, Navaline, H, Woody, G E, McLellan, A T
Publicado em 1994

Ligand-activated site-specific recombination in mice.

Por Feil, R, Brocard, J, Mascrez, B, LeMeur, M, Metzger, D, Chambon, P
Publicado em 1996

Initial studies of the structural signal for extracellular transport of cholera toxin and other proteins recognized by Vibrio cholerae.

Por Connell, T D, Metzger, D J, Wang, M, Jobling, M G, Holmes, R K
Publicado em 1995

Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7

Por Rocher-Ros, V, Marco, S, Mao, J-H, Gines, S, Metzger, D, Chambon, P, Balmain, A, Saura, CA
Publicado em 2010

Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) reco...

Por Indra, A K, Warot, X, Brocard, J, Bornert, J M, Xiao, J H, Chambon, P, Metzger, D
Publicado em 1999